Palisade Capital Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Palisade Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Palisade Capital Management from 13F filings

Historical chart of Palisade Capital Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Palisade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Palisade Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.9M 2.6M 1.11
2024-03-31 $3.5M 3.6M 0.97
2023-12-31 $3.6M 3.9M 0.93
2023-09-30 $3.6M 3.9M 0.93

More positions owned by Palisade Capital Management

Raymond James Financial (RJF)
Mueller Industries (MLI)
Applied Industrial Technologies (AIT)
Apple (AAPL)
Avient Corp (AVNT)
Littelfuse (LFUS)
Primo Water (PRMW)
Ida (IDA)
Texas Roadhouse (TXRH)
Verra Mobility Corp Cl A Com Stk (VRRM)
ACI Worldwide (ACIW)
Blackbaud (BLKB)
Onto Innovation (ONTO)
Acadia Healthcare (ACHC)
Rli (RLI)

View all positions for Palisade Capital Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1